CLINICAL ROLE -
Richard Furie, MD, is Chief of the Division of Rheumatology at Northwell Health.
Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients
Obinutuzumab is effective in reducing proteinuria and preserving kidney function in lupus nephritis, with consistent benefits across high-disease activity subgroups.
Read More